LEAP2: A first-in-human evaluation of a chronically implanted novel leadless pacemaker for conduction system pacing
Heart Rhythm · 2026-09 · 23 (9) · 1978-1987
DOI: 10.1016/j.hrthm.2026.04.014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Heart Rhythm, 2026-09. Verfasst von Vivek Y Reddy und 10 weiteren Autor:innen. Beteiligte Einrichtung: Helmsley Electrophysiology Center, Mount Sinai Fuster Heart Hospital, New York, New York; Charles University and Faculty Hospitals Motol and Homolka,…. Hauptthemen laut MEDLINE: Pacemaker, Artificial, Cardiac Pacing, Artificial, Heart Conduction System. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Abbott Pharmaceuticals, Abbott Vascular Inc.
Abstract (Originalsprache)
BACKGROUND: In a first-in-human acute "pass-pull" study, we previously demonstrated that a novel leadless pacemaker (LP) for conduction system pacing (CSP) could acutely pace the deep interventricular septum (IVS). OBJECTIVE: This study aimed to evaluate the safety and efficacy of chronically implanted LPCSP. METHODS: In this study, pacemaker-indicated patients received the Aveir-CSP leadless pacemaker (LPCSP) as either a standalone ventricular pacemaker or as a dual-chamber system paired with an atrial LP. Introduced via the right internal jugular vein, the LPCSP was implanted under fluoroscopic and intra-cardiac echocardiography guidance. The primary safety end point was complications at 1-month. Electrical performance (capture threshold at 0.4 ms, R-wave amplitude, impedance) and capture type (left bundle branch pacing [LBBP] vs left ventricular septal pacing [LVSP] vs deep septal pacing [DSP]) were assessed at implant and at 1 month. RESULTS: Among 20 enrolled patients, 1 was withdrawn for challenging anatomy. LPCSP implantation was successful in 18 of 19 patients: 4 ventricular-only and 14 dual-chamber. At implant, capture thresholds, R-wave amplitudes, and impedance were acceptable, and at 1 month, they were 1.3 ± 0.6 V, 13.1 ± 4.0 mV, and 490 ± 72 Ω, respectively. The capture type at implant was LBBP in 9, LVSP in 5, and DSP in 4 patients, but changed in 6 patients by 1-month follow-up. In addition, 3 patients had dislodgements. For dual-chamber implants, implant-to-implant communication was stable through 1-month. The 1-month LPCSP complication-free-rate was 73.7%; 5 patients experienced complications, including internal jugular-access hematoma, LPCSP dislodgements, and dislocation. CONCLUSION: This first-in-human evaluation demonstrated the feasibility of leadless CSP, but improvements in LPCSP stability fixation require further evaluation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Helmsley Electrophysiology Center, Mount Sinai Fuster Heart Hospital, New York, New York; Charles University and Faculty Hospitals Motol and Homolka, Prague, Czech Republic. Electronic address: vivek.reddy@mountsinai.or…
- St. Bernards Medical Center & Arrhythmia Research Group, Jonesboro, Arkansas.
- Charles University and Faculty Hospitals Motol and Homolka, Prague, Czech Republic.
- ASU School of Medicine and Medical Engineering, Scottsdale, Arizona.
- Pacific Heart Institute, Santa Monica, California.
- Cardiac Rhythm Management, Abbott, Sylmar, California.
Förderung
- Abbott Pharmaceuticals
- Abbott Vascular Inc
Zitieren
APA
Reddy, V. Y., Nair, D. G., Chovanec, M., Doshi, R. N., Doshi, S. K., Jiang, C., Sabet, L., Charan, V., Ryu, K., Ganz, L. I., & Neuzil, P. (2026). LEAP2: A first-in-human evaluation of a chronically implanted novel leadless pacemaker for conduction system pacing. Heart Rhythm, 23(9), 1978-1987. https://doi.org/10.1016/j.hrthm.2026.04.014
Vancouver
Reddy VY, Nair DG, Chovanec M, Doshi RN, Doshi SK, Jiang C, et al. LEAP2: A first-in-human evaluation of a chronically implanted novel leadless pacemaker for conduction system pacing. Heart Rhythm. 2026;23(9):1978-1987. doi:10.1016/j.hrthm.2026.04.014
BibTeX
@article{Reddy2026,
author = {Reddy, Vivek Y and Nair, Devi G and Chovanec, Milan and Doshi, Rahul N and Doshi, Shephal K and Jiang, Chunlan and Sabet, Leyla and Charan, Vishnu and Ryu, Kyungmoo and Ganz, Leonard I and Neuzil, Petr},
title = {LEAP2: A first-in-human evaluation of a chronically implanted novel leadless pacemaker for conduction system pacing},
journal = {Heart Rhythm},
year = {2026},
volume = {23},
number = {9},
pages = {1978--1987},
doi = {10.1016/j.hrthm.2026.04.014}
}
EUVIMED